Q&A: Anal screening pioneer explains his landmark findings

Professor Joel Palefsky has high hopes that screening will prove cost-effective
Professor Joel Palefsky
Professor Joel Palefsky.

The recent ANCHOR trial has demonstrated for the first time that anal screening for precursor lesions can reduce the risk of invasive cancer.

The infectious diseases specialist behind the study is HPV expert Professor Joel Palefsky, professor of medicine and laboratory medicine at the University of California San Francisco (UCSF).